Tragara Pharmaceuticals

Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Tragara launched operations in January 2007 and is focusing its development resources on two programs: (1) TP1001 for the treatment of inflammation related disorders and (2) TP2001 for the treatment of solid tumors.

Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics.


Date Type Amount Investors Valuation
03/01/07 Series A 40M Domain Associates, ProQuest Investments, Morgenthaler Ventures, Bioscience Partners, Mitsubishi International Corporation Unknown


Thomas Estok (President/CEO)

Tracy Lawhon (VP Regulatory Affairs & Development Operations)

Chris LeMasters (Chief Business Officer)

Sara Zaknoen (Chief Medical Officer)

Kim Kamdar (Board Member)

View more details about all 9 people at Tragara Pharmaceuticals